Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Remarks:
BASF AG, Experimental Toxicology and Ecology
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Cyclohexane, oxidized, aq. ext., sodium salt
EC Number:
272-812-5
EC Name:
Cyclohexane, oxidized, aq. ext., sodium salt
Cas Number:
68915-39-9
Molecular formula:
Unspecified (UVCB substance)
IUPAC Name:
Cyclohexane, oxidized, aq. ext., sodium salt
Details on test material:
- Name of test material (as cited in study report): Natriumcarboxylat-Loesung
- Physical state: Liquid, brown, clear
- Composition of test material, percentage of components: Aqueous solution (about 53.6% water)
- Lot/batch No.: Probe EX 1672
- Stability under test conditions: stable under storage conditions throughout the study period
- Storage condition of test material: Room temperature

Method

Target gene:
his, trp
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
phenobarbital and β-naphthoflavone induced S9 mix
Test concentrations with justification for top dose:
Standard plate test (SPT) with and without S9 mix: 0, 44, 220, 1100, 5500 and 11000 μg/plate;
Preincubation test (PIT) with and without S9 mix: 0, 687.5, 1375, 2750, 5500 and 11000 μg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: water
- Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, water was used as vehicle.
Controlsopen allclose all
Untreated negative controls:
yes
Remarks:
sterility control
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
other: 2-aminoanthracene, dissolved in DMSO for all strains
Remarks:
with S9 mix
Untreated negative controls:
yes
Remarks:
sterility control
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
other: N-ethyl-N-nitro-N-nitrosoguanidine, 5 μg/plate, dissolved in DMSO for TA 1535, TA 100
Remarks:
without S9 mix
Untreated negative controls:
yes
Remarks:
sterility control
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
other: 4-nitro-o-phenylenediamine, 10 μg/plate, dissolved in DMSO for TA 98
Remarks:
without S9 mix
Untreated negative controls:
yes
Remarks:
sterility control
Negative solvent / vehicle controls:
yes
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
without S9 mix

Migrated to IUCLID6: 100 μg/plate, dissolved in DMSO for TA 1537
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

PROCEDURE
- The experimental procedure of the standard plate test (plate incorporation method) was based on the method of Ames et al. (Mut. Res., 31, 347 - 364, 1975)
- The experimental procedure of the Preincubation Test was based on the method described by Yahagi et al. (Mut. Res., 48, 121 - 130, 1977) and Matsushima et al (In: Norpoth, K.H. and R.C. Garner, Short-Term Test Systems for Detecting Carcinogens. Springer Verlag Berlin, Heidelberg, New York, 1980)
Evaluation criteria:
- The test chemical is considered positive in this assay if a dose-related and reproducible increase in the number of revertant colonies, i.e. about
doubling of the spontaneous mutation rate in at least one tester strain either without S9 mix or after adding a metabolizing system.
- A test substance is generally considered non-mutagenic in this test if the number of revertants for all tester strains were within the historical negative control range under all experimental conditions in at least two experiments carried out independently of each other.

Results and discussion

Test resultsopen allclose all
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 11000 μg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
at 11000 μg/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: No test substance precipitation was found with and without S9 mix.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Standard Plate Test: Mean Revertants per plate

Dose (µg/plate)

        TA 98

       TA 100

      TA 1535

      TA 1537

      WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

0

30±5

30±2

98±4

99±8

14±1

14±2

9±2

9±3

38±6

43±3

44

29±4

27±1

102±8

103±28

16±2

18±2

10±3

8±2

39±5

38±5

220

27±7

24±9

96±7

96±5

12±2

14±3

8±2

8±2

40±3

45±3

1100

21±3

22±4

96±6

102±4

14±4

15±4

8±2

10±1

40±2

43±6

5500

26±5

24±4

112±18

107±13

14±3

15±1

7±0

8±2

38±6

47±5

11000

22±6

26±1

89±8

103±19

13±5

12±2

6±3

8±3

37±3

48±7

PC

715±31

899±24

720±85

623±12

710±48

151±31

353±21

179±40

1093±49

212±51

 

Plate Incubation Test: Mean Revertants per plate

Dose (µg/plate)

        TA 98

       TA 100

      TA 1535

      TA 1537

      WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

0

25±4

33±5

92±18

92±1

10±2

13±4

7±2

7±2

36±1

44±3

687.5

21±4

32±6

88±4

101±2

14±4

14±2

9±2

5±1

45±10

38±5

1375

22±6

38±5

91±10

95±5

11±2

11±3

8±3

4±1

37±2

48±5

2750

19±3

33±7

93±8

95±15

14±2

9±3

9±1

6±3

39±3

51±3

5500

24±3

33±8

93±11

109±7

8±2

11±4

10±2

7±3

41±3

52±5

11000

17±5

2±7

107±3

76±2

10±4

9±2

9±3

5±1

39±5

46±4

PC

627±19

546±44

803±32

522±35

1557±120

84±2

238±6

76±6

836±6

156±3

 PC: positive control

Applicant's summary and conclusion